Investor Presentation BALAXI PHARMACEUTICALS LIMITED has informed the Exchange about Investor Presentation BALAXI PHARMACEUTICALS LIMITED has informed the Exchange about Investor Presentation
Investor Presentation BALAXI PHARMACEUTICALS LIMITED has informed the Exchange about Investor Presentation BALAXI PHARMACEUTICALS LIMITED has informed the Exchange about Investor Presentation
Outcome of Board Meeting BALAXI PHARMACEUTICALS LIMITED has submitted to the Exchange, the financial results for the period ended March 31, 2026. BALAXI PHARMACEUTICALS LIMITED has submitted to the Exchange, the financial results for the period ended March 31, 2026.
BALAXI PHARMACEUTICALS Q3 FY25 Results
BALAXI PHARMACEUTICALS Q2 FY25 Results
NSE & BSE filings, earnings, insider trades, and smart volume alerts — on WhatsApp or Telegram. No separate app to install.
Filings and alerts in WhatsApp or Telegram
Focus on news that matter most to you
Track 5 companies at no cost. Upgrade anytime.